CTLA-4 (CTLA4)

What it is. T-cell inhibitory receptor that competes with CD28 for co-stimulatory ligands (CD80/CD86).

Why it matters here. Key immune brake exploited by tumors; validated therapeutic target (checkpoint blockade).

Notes. Therapy: anti-CTLA-4 antibodies (e.g., ipilimumab).